Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 Jun 17;20(6):e0310163.
doi: 10.1371/journal.pone.0310163. eCollection 2025.

Prevalence of dengue in febrile patients in Peru: A systematic review and meta-analysis

Darwin A León-Figueroa  1   2 , Edwin A Garcia-Vasquez  1 , Milagros Diaz-Torres  1 , Edwin Aguirre-Milachay  3 , Jean Pierre Villanueva-De La Cruz  4 , Hortencia M Saldaña-Cumpa  1 , Mario J Valladares-Garrido  5
Affiliations
Meta-Analysis

Prevalence of dengue in febrile patients in Peru: A systematic review and meta-analysis

Darwin A León-Figueroa et al. PLoS One. .

Abstract

Background: Dengue is an acute febrile illness that is a significant public health problem. Peru is an endemic region for vector-borne diseases such as dengue, zika, and chikungunya, which initially manifest with febrile illness and can complicate differential diagnosis. Therefore, the present study aimed to determine the prevalence of positive results for dengue or dengue antibodies in Peruvian patients with febrile illness using diagnostic tools such as RT-PCR and ELISA NS1, IgM, and IgG.

Methods: A literature search was conducted in eight databases or search tools (PubMed, Scopus, Embase, Web of Science, ScienceDirect, Google Scholar, Virtual Health Library, and Scielo) until June 9, 2024. Medical Subject Headings (MeSH) terms such as "dengue" and "Peru" were used, together with the free term "febrile illness", combined using the Boolean operators AND and OR. We included observational studies with a control group of patients with fever but no dengue infection and a non-control group of febrile patients who tested positive for dengue. Pooled estimates and 95% confidence intervals (CI) were calculated using random-effects models. Study quality and risk of bias were assessed using the Joanna Briggs Institute Statistical Meta-Analysis Assessment and Review Instrument. Heterogeneity was assessed using the I2 statistic, and statistical analysis was performed with R version 4.2.3.

Results: We included 15 observational studies that met the inclusion criteria developed in 10 regions of Peru and published between 2002 and 2022, with a total of 12,355 patients with febrile illness. The pooled prevalence of positive results for dengue or dengue antibodies in these patients was 21% (95% CI: 9%-36%; 2022 participants; 5 studies; I2 = 98%) for IgG ELISA, 16% (95% CI: 11%-21%; 10891 participants; 10 studies; I2 = 97%) for IgM ELISA, 19% (95% CI: 9%-31%; 2086 participants; 5 studies; I2 = 98%) for NS1 ELISA, and 20% (95% CI: 13%-28%; 3107 participants; 9 studies; I2 = 96%) for RNA PCR.

Conclusion: Our results suggest a high prevalence of positive results for dengue or dengue antibodies among febrile patients in Peru, which varies depending on the diagnostic method used. Despite this variability, the use of accurate diagnostic methods is essential for the early detection and prevention of serious complications. The findings underline the need to strengthen dengue control strategies, improve diagnostic capacity in health centers, and optimize epidemiological surveillance in high-incidence regions. It is recommended that public health policies focus on these key areas for better management of the disease.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Study selection process based on the PRISMA flowchart.
Fig 2
Fig 2. Pooled prevalence of positive results for dengue or dengue antibodies in Peruvian patients with febrile illness by IgG ELISA.
Fig 3
Fig 3. Pooled prevalence of positive results for dengue or dengue antibodies in Peruvian patients with febrile illness by IgM ELISA.
Fig 4
Fig 4. Pooled prevalence of positive results for dengue or dengue antibodies in Peruvian patients with febrile illness by NS1 ELISA.
Fig 5
Fig 5. Pooled prevalence of positive results for dengue or dengue antibodies in Peruvian patients with febrile illness by RNA PCR.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Raab M, Pfadenhauer LM, Doumbouya D, Froeschl G. Clinical presentations, diagnostics, treatments and treatment costs of children and adults with febrile illness in a tertiary referral hospital in south-eastern Guinea: A retrospective longitudinal cohort study. PLoS One. 2022;17(1):e0262084. doi: 10.1371/journal.pone.0262084 - DOI - PMC - PubMed
    1. Jiménez-Morillas F, Gil-Mosquera M, García-Lamberechts EJ, INFURG-SEMES tropical diseases department. Fever in travellers returning from the tropics. Med Clin (Engl Ed). 2019;153(5):205–12. doi: 10.1016/j.medcle.2019.03.013 - DOI - PMC - PubMed
    1. Crump JA, Gove S, Parry CM. Management of adolescents and adults with febrile illness in resource limited areas. BMJ. 2011;343:d4847. doi: 10.1136/bmj.d4847 - DOI - PMC - PubMed
    1. Bressan CdaS, Teixeira M de LB, Gouvêa MIF da S, de Pina-Costa A, Santos HFP, Calvet GA, et al. Challenges of acute febrile illness diagnosis in a national infectious diseases center in Rio de Janeiro: 16-year experience of syndromic surveillance. PLoS Negl Trop Dis. 2023;17(4):e0011232. doi: 10.1371/journal.pntd.0011232 - DOI - PMC - PubMed
    1. Kigozi BK, Kharod GA, Bukenya H, Shadomy SV, Haberling DL, Stoddard RA, et al. Investigating the etiology of acute febrile illness: a prospective clinic-based study in Uganda. BMC Infect Dis. 2023;23(1):411. doi: 10.1186/s12879-023-08335-4 - DOI - PMC - PubMed